BioAlliance appoints Pierre Morgon chief operating officer
This article was originally published in Scrip
Executive Summary
BioAlliance Pharma (France), a speciality pharmaceutical company focused on the treatment of infections in cancer and HIV, has strengthened its management board with the appointment of Pierre Morgon as chief operating officer. He joins from Schering-Plough France, where he managed primary care operations in France for two years and the partnership with MSD. From 2004 to 2006, Mr Morgon was vice-president of hospital operations at Bristol-Myers Squibb, and from 2003 to 2004 he served as general manager of Yamanouchi Pharma France.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.